LENZ Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€4.31M - Cost of goods sold
€30.15K - Gross profit
€4.30M - SG&A expenses
€34.25M - R&D expenses
€23.43M - EBITDA
-€53.30M - D&A
€77.54K - EBIT
-€53.38M - Interest expenses
€0.00 - EBT
-€44.71M - Tax expenses
€431.64K - Net income
-€45.14M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€4.06M - Changes in working capital
€497.98K - Operating cash flow
-€40.68M - Capex
€590.16K - Other investing cash flow
€0.00 - Net investing cash flow
-€47.91M - Total cash dividends paid
€0.00 - Issuance of common stock
€48.09M - Debt repayment
€0.00 - Other financing cash flow
€508.31K - Net financing cash flow
€48.59M - Foreign exchange effects
€0.00 - Net change in cash
-€40.00M - Cash at end of period
€32.50M - Free cash flow
-€40.09M
Balance sheet
- Cash and cash equivalents
€32.40M - Cash and short-term investments
€180.51M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€3.52M - Total current assets
€184.03M - Property, plant & equipment
€1.83M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€1.38M - Total non-current assets
€3.21M - Total assets
€187.24M - Accounts payable
€2.46M - Short-term debt
€415.27K - Other current liabilities
€6.08M - Total current liabilities
€8.96M - Long-term debt
€490.22K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€490.22K - Total liabilities
€9.45M - Common stock
€861.55 - Retained earnings
-€150.38M - Other equity
€32.74K - Total equity
€177.79M - Total liabilities and shareholders' equity
€187.24M
Company information
- Market capitalization
€574.27M - Employees
6 - Enterprise Value
€822.53M
Company ratios
- Gross margin
-
99.8% - EBITDA margin
-
-1,237.4% - EBIT margin
-
-1,239.2% - EBT margin
-
-1,037.9% - Net margin
-
-1,048.0% - ROE
-
-25.4% - ROA
-
-24.1% - Asset turnover
-
2.3% - FCF margin
-
-958.0% - FCF yield
-7.2% - Efficiency ratio
1,337.4% - Net sales per employee
-
€717.96K - Net income per employee
-
-€7.52M